Correlation Between Algernon Pharmaceuticals and Genelux Common
Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and Genelux Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and Genelux Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Algernon Pharmaceuticals and Genelux Common, you can compare the effects of market volatilities on Algernon Pharmaceuticals and Genelux Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of Genelux Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and Genelux Common.
Diversification Opportunities for Algernon Pharmaceuticals and Genelux Common
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Algernon and Genelux is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and Genelux Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genelux Common and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with Genelux Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genelux Common has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and Genelux Common go up and down completely randomly.
Pair Corralation between Algernon Pharmaceuticals and Genelux Common
Assuming the 90 days horizon Algernon Pharmaceuticals is expected to generate 1.79 times more return on investment than Genelux Common. However, Algernon Pharmaceuticals is 1.79 times more volatile than Genelux Common. It trades about 0.04 of its potential returns per unit of risk. Genelux Common is currently generating about -0.08 per unit of risk. If you would invest 5.85 in Algernon Pharmaceuticals on August 28, 2024 and sell it today you would lose (0.15) from holding Algernon Pharmaceuticals or give up 2.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Algernon Pharmaceuticals vs. Genelux Common
Performance |
| Timeline |
| Algernon Pharmaceuticals |
| Genelux Common |
Algernon Pharmaceuticals and Genelux Common Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Algernon Pharmaceuticals and Genelux Common
The main advantage of trading using opposite Algernon Pharmaceuticals and Genelux Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, Genelux Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genelux Common will offset losses from the drop in Genelux Common's long position.The idea behind Algernon Pharmaceuticals and Genelux Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Genelux Common vs. Dyadic International | Genelux Common vs. Cingulate | Genelux Common vs. Monopar Therapeutics | Genelux Common vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |